Skip to main content


Medical Oncology

Medical Oncology 3/2005

Ausgabe 3/2005

Inhaltsverzeichnis ( 13 Artikel )

01.09.2005 | Review | Ausgabe 3/2005

Prognostic usage of VH gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia

Gerard Tobin PhD, Richard Rosenquist

01.09.2005 | Original Article | Ausgabe 3/2005

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

Nissim Haim, Katerina Shulman, Hadassah Goldberg, Medy Tsalic

01.09.2005 | Original Article | Ausgabe 3/2005

Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers

C. Abrial, M. A. Mouret-Reynier, S. Amat, I. Sillet-Bach, P. Bougnoux, R. Delva, H. Cure, J. Dauplat, F. Penault-Llorca, P. Chollet

01.09.2005 | Original Article | Ausgabe 3/2005

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma

Serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma
Faruk Tas MD, Hilal Oguz PhD, Andaç Argon MD, Derya Duranyildiz PhD, Hakan Camlica MD, Vildan Yasasever PhD, Erkan Topuz MD

01.09.2005 | Original Article | Ausgabe 3/2005

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy

A multicenter open randomized phase III study
Giuseppe Masucci, Peter Broman, Charles Kelly, Sten Lindahl, Lena Malmberg, Johan Reizenstein, Martin Ålenius, Rolf Lewensohn

01.09.2005 | Original Article | Ausgabe 3/2005

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

Joseph A. Sparano MD, Abdissa Negassa, Erick Lansigan, Robin Locke, Chamath R. De Silva, Peter H. Wiernik

01.09.2005 | Original Article | Ausgabe 3/2005

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck

A hellenic cooperative oncology group phase II study
George Fountzilas MD, Christos Tolis, Anna Kalogera-Fountzila, Despina Misailidou, Periklis Tsekeris, Maria Karina, Angelos Nikolaou, Epaminondas Samantas, Thomas Makatsoris, Eleni Athanassiou, Dimosthenis Skarlos, Aristotelis Bamias, Nikolas Zamboglou, Theofanis Economopoulos, Sophia Karanastassi, Nicholas Pavlidis, John Daniilidis

01.09.2005 | Original Article | Ausgabe 3/2005

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

Ji-Youn Han, Dae Ho Lee, Sung Young Lee, Chun Gun Park, Hae Young Kim, Eun-A Kim, Sung Min Yoon, Hong Gi Lee, Jin Soo Lee MD

01.09.2005 | Original Article | Ausgabe 3/2005

Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL)

Comparison of indolent and progressive disease
Shahryar Kiaii, Aniruddha Choudhury, Fariba Mozaffari, Eva Kimby, Anders Österborg, Håkan Mellstedt MD, PhD

01.09.2005 | Original Article | Ausgabe 3/2005

Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases

A multicenter phase II study by the cancer therapeutic research group
Wing M. Ho, B. Ma, Tony Mok, W. Yeo, Paul Lai, R. Lim, Jane Koh, Y. Y. Wong, Ann King, C. K. Leow, A. T. C. Chan MD

01.09.2005 | Case | Ausgabe 3/2005

Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission

Hakan Karagol MD, Duygu Derin, Mert Basaran, Sevil Bavbek

01.09.2005 | Case | Ausgabe 3/2005

Mantle cell lymphoma presenting with paraproteinemia

Grzegorz Rymkiewicz MD, Monika Gos, Katarzyna Błachnio, Renata Woroniecka, Paweł Swoboda, Barbara Pieńkowska-Grela, Marika Kulińska, Anna Borawska, Przemysław Janik, Jan Walewski

01.09.2005 | Ausgabe 3/2005

Book review

Janis Racevskis PhD

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.